Stock IGMS IGM BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News IGM Biosciences, Inc.

Equities

IGMS

US4495851085

Real-time Estimate Cboe BZX
Other stock markets
 09:34:05 2024-04-30 am EDT 		5-day change 1st Jan Change
9.285 USD -4.28% Intraday chart for IGM Biosciences, Inc. +43.70% +16.73%
Apr. 17 IGM Biosciences, Sanofi Narrow Partnership to Focus on Potential Immunology and Inflamation Targets MT
Apr. 17 IGM Biosciences, Inc. Announces Refocusing of Sanofi Collaboration CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
IGM Biosciences, Sanofi Narrow Partnership to Focus on Potential Immunology and Inflamation Targets
MT
IGM Biosciences Announces Refocusing of Sanofi Collaboration
GL
IGM Biosciences, Inc. Announces Refocusing of Sanofi Collaboration
CI
IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
GL
North American Morning Briefing : Stocks Set for -2-
DJ
HC Wainwright Adjusts IGM Biosciences Price Target to $12 From $7, Maintains Neutral Rating
MT
Earnings Flash (IGMS) IGM BIOSCIENCES Reports Q4 Revenue $651,000
MT
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
GL
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
AQ
IGM Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
IGM Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
MEDIVIR AB - YEAR-END REPORT JANUARY - DECEMBER 2023
AQ
North American Morning Briefing : Stock Futures -2-
DJ
RBC Upgrades IGM Biosciences to Outperform From Sector Perform, Boosts Price Target to $21 From $9; Speculative Risk Kept
MT
IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
GL
IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
AQ
Transcript : IGM Biosciences, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 11:15 AM
IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
GL
North American Morning Briefing : Stock Futures -2-
DJ
BofA Securities Downgrades IGM Biosciences to Neutral From Buy, Adjusts Price Target to $8 From $20
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IGMS Stock
  4. News IGM Biosciences, Inc.